NICE on the offensive in row over breast cancer drug

By Sarah Calkin2014-08-08T00:01:00

NICE has taken the unprecedented step of expressing its ‘disappointment’ with a multinational drug giant in a row over a new breast cancer drug and the government’s pricing deal

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
10 expert briefings every fortnight (Premium only)
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

to HSJ

Already a subscriber? Sign into your account here